A Patient-cantered Approach to Quality Assurance and Radiation Safety in Nuclear Medicine and Radiation Therapy

Ekmek Cioglu^*
*Correspondence: Ekmek Cioglu, Department of Molecular and Cellular Biology, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland, Email:

Introduction

A patient-centered approach to QA and radiation safety not only improves clinical outcomes but also enhances patient experience, minimizes potential harm, and fosters trust in healthcare systems. This approach integrates multidisciplinary teams, robust protocols, and continuous monitoring to achieve the best possible outcomes for individuals undergoing nuclear medicine or radiation therapy procedures. The enhanced accuracy enables radiation oncologists to tailor treatment plans with greater specificity, ensuring that the radiation is concentrated on the cancerous cells while sparing nearby normal tissues. Another significant development is the utilization of intensity-modulated radiation therapy and volumetric modulated arc therapy. These techniques enable the adjustment of radiation intensity and delivery angles during treatment, allowing for a more conformal and precise dose distribution. This adaptability is particularly beneficial when treating tumors located near critical structures or in complex anatomical regions. One notable advancement in radiation therapy is the increasing use of advanced imaging techniques for treatment planning. The integration of technologies like magnetic resonance imaging and positron emission tomography into the planning process allows for a more precise delineation of the tumor and surrounding healthy tissues [1].

Description

In the fields of nuclear medicine and radiation therapy, quality assurance (QA) and radiation safety are essential components of delivering effective and safe patient care. The application of radioactive materials for diagnostic imaging or treatment must be handled with the highest standards of safety, precision, and consistency to minimize risks while maximizing therapeutic benefits. This is particularly critical when the patient is the focus, ensuring their well-being, comfort, and safety throughout their treatment process. This real-time imaging allows for the adjustment of radiation beams during treatment sessions to account for any tumor movement or changes in anatomy. IGRT significantly enhances treatment accuracy, particularly for tumors located near critical organs or structures. IMRT is a highly sophisticated technique that enables the precise shaping of radiation beams to conform to the shape of the tumor. Radiation therapy, also known as radiotherapy, has a rich history of development and evolution spanning over a century. It has become a critical component of cancer treatment and has evolved significantly in terms of technology, precision and effectiveness. This article explores the remarkable journey of radiation therapy from its early beginnings to the current era of precision medicine. Early experiments with radioactive substances, such as radium and radon, were conducted to explore their potential therapeutic effects on tumors. However, these experiments lacked the precision and control required for safe and effective treatment. The advent of linear accelerators in the mid-20th century revolutionized radiation therapy. These machines generate high-energy X-rays and electron beams, offering precise control over radiation delivery. Radiation therapy is increasingly used in combination with other treatments, such as surgery, chemotherapy and immunotherapy. This approach enhances treatment effectiveness by addressing cancer from multiple angles [2].

The patient-centered approach to care emphasizes the needs, preferences, and values of the patient throughout their treatment journey. In radiation therapy and nuclear medicine, this approach requires tailored treatment plans, clear communication, patient involvement in decision-making, and continuous support to ensure both the effectiveness of the treatment and the safety of the patient. Traditional radiation therapy has traditionally relied on standard treatment protocols, where the same radiation doses and techniques were applied to a broad spectrum of cancer patients. While effective, this one-size-fits-all approach often resulted in unnecessary radiation exposure to healthy tissues and suboptimal outcomes for some patients. Proton therapy, which uses charged protons instead of X-rays, offers even greater precision and minimal damage to surrounding tissues. It is particularly beneficial for pediatric cancers and tumors near critical structures. Today, radiation therapy is becoming an integral part of personalized cancer treatment. Treatment plans are tailored to each patient's unique anatomy, tumor characteristics and overall health. This approach maximizes cancer control while minimizing side effects. IGRT involves the use of advanced imaging techniques, such as CT scans or MRI, to precisely visualize the tumor and surrounding structures in real-time [3].

In radiation therapy, this means providing precise radiation delivery to the tumor while minimizing exposure to surrounding healthy tissues. In nuclear medicine, this means carefully selecting the right radiopharmaceutical, ensuring proper imaging protocols, and minimizing unnecessary radiation exposure. As our understanding of cancer biology continues to expand, radiation therapy is poised to play an increasingly vital role in the fight against cancer, offering hope to patients for more effective and less invasive treatments. The repurposing of chronically used drugs in cancer therapy offers an exciting avenue for advancing cancer treatment and improving patient outcomes. By leveraging existing knowledge and therapeutic options, researchers have the opportunity to explore unconventional approaches to combat cancer effectively. Advanced imaging and treatment planning software allow oncologists to create highly individualized treatment plans that consider a patient's unique anatomy, tumor characteristics and overall health. Personalized treatment strategies may involve dose escalation, where higher radiation doses are delivered to more aggressive tumors or hypofractionation, which shortens treatment duration. Some radiation centers employ adaptive therapy, where treatment plans are continuously adjusted based on a patient's response to treatment and changes in tumor size and position. Radiation therapy is often combined with other treatments, such as surgery, chemotherapy, or immunotherapy, to maximize cancer control while minimizing side effects [4,5].

Conclusion

The advances in radiation therapy have transformed cancer treatment into a highly personalized and precise endeavor. Tailoring treatment strategies to individual patients not only improves outcomes but also reduces the burden of side effects. As technology continues to evolve and our understanding of cancer biology deepens, radiation therapy is poised to play an increasingly vital role in the fight against cancer, offering hope to patients worldwide for more effective and less invasive treatments.

Acknowledgement

None.

Conflict of Interest

There is no conflict of interest by author.

References

1. Herrmann, Inge Katrin, Matthew John Andrew Wood and Gregor Fuhrmann. "Extracellular vesicles as a next-generation drug delivery platform." Nat Nanotechnol 16 (2021): 748-759.

Google Scholar, Crossref, Indexed at

2. Théry, Clotilde, Armelle Regnault, Jérôme Garin and Joseph Wolfers, et al. "Molecular characterization of dendritic cell-derived exosomes: Selective accumulation of the heat shock protein hsc73." J Cell Biol 147 (1999): 599-610.

Google Scholar, Crossref, Indexed at

3. Gross, Julia Christina, Varun Chaudhary, Kerstin Bartscherer and Michael Boutros. "Active wnt proteins are secreted on exosomes." Nat Cell Biol 14 (2012): 1036-1045.

Google Scholar, Crossref, Indexed at

4. Szwedowicz, Urszula, Zofia Łapińska, Agnieszka Gajewska-Naryniecka and Anna Choromańska. "Exosomes and other extracellular vesicles with high therapeutic potential: Their applications in oncology, neurology and dermatology." Molecules 27 (2022): 1303.

Google Scholar, Crossref, Indexed at

5. Willms, Eduard, Carlos Cabañas, Imre Mäger and Matthew JA Wood, et al. "Extracellular vesicle heterogeneity: Subpopulations, isolation techniques and diverse functions in cancer progression." Front Immunol 9 (2018): 738.

Google Scholar, Crossref, Indexed at